MGX Proyeksi bathi mangsa ngarep Metagenomi

Simbol lan logo merek Metagenomi, Inc. (MGX)

Metagenomi, Inc. (MGX) is investing in the discovery of new CRISPR systems to combat hereditary pathologies. Developing precision editing tools in alliance with biotech giants minimizes risks. The company's pre-revenue status makes it dependent on investor capital. Expected profit growth demonstrates the dynamics of market expectations, and reflects the latest metric value determining the current valuation of future prospects.

MGX: Bathi resik sing dikarepake Metagenomi, Inc. 04.07.2022 - 18.11.2026

Rincian metrik lan analitis perusahaan Metagenomi Therapeutics (MGX)

- rega saham lan konsensus proyeksi valuasi:
Analisis komprehensif perusahaan:Metagenomi Inc., MGX
Barang utama Metagenomi, Inc

Projected profit reflects the expected net return of the business, accounting for future cash flows. By analyzing this chart of estimated future earnings, an investor assesses the asset's capitalization potential. This metric synthesizes current margins and revenue growth rates. For Metagenomi, Inc. (MGX), the stability of this indicator confirms the effectiveness of pipeline diversification across oncology and genetics. Partnerships with pharma behemoths reduce expectation volatility, minimizing early-stage development risks.

Analisis pesaing

Bathi sing dikarepake Tempus AI|Proyeksi bathi mangsa ngarep Qiagen|Proyeksi bathi mangsa ngarep IONS|Bathi sing dikarepake RGEN (Repligen Corp.)|Avidity - Bathi mangsa ngarep|CRSP (crisprtx.com) - Bathi forward|WGS: Bathi mangsa ngarep|Proyeksi bathi resik Ultragenyx (RARE)|BEAM: Proyeksi bathi mangsa ngarep|Sarepta Therapeutics, Inc. (SRPT) - Proyeksi bathi mangsa ngarep|TWST (twistbioscience.com) - Proyeksi bathi mangsa ngarep|10x Genomics, Inc. (TXG) - Prakiraan bathi perusahaan|Bathi mangsa ngarep NTLA (Intellia Therapeutics, Inc.)|STOK - Bathi resik sing dikarepake|Bathi sing dikarepake biolifesolutions.com BLFS|Prakiraan bathi perusahaan Wave Life Sciences Corp (WVE)|MAZE - Bathi sing dikarepake|Penghasilan resik sing dikarepake SION (Sionna Therapeutics Inc)|PRME: Proyeksi bathi mangsa ngarep|Taysha - Penghasilan resik sing dikarepake|Bathi sing dikarepake uniQure NV|Prakiraan bathi resik MGTX (MeiraGTx PLC)|Bathi mangsa ngarep RGNX (regenxbio.com)|Solid Biosciences Inc. - Prakiraan bathi resik|Bathi sing dikarepake Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Bathi resik sing dikarepake|BNTC - Bathi sing dikarepake|Design Pharma - Bathi resik mangsa ngarep|RCKT (Rocket Pharmaceuticals Inc) - Bathi mangsa ngarep|4D Molecular Therapeutics (FDMT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Lexeo Therapeutics, Inc.|Bathi resik sing dikarepake Korro Bio, Inc. KRRO|Proyeksi bathi mangsa ngarep EDIT|Prakiraan bathi perusahaan Silence Therapeutics Corp|Bathi sing dikarepake proqr.com PRQR|CDXS - Bathi mangsa ngarep|SGMO - Bathi sing dikarepake|Proyeksi bathi resik Nautilus Biotechnology, Inc. (NAUT)|DTIL: Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Generation Bio Co (GBIO)|BOLD (Boundless Bio) - Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Exicure (XCUR)|Bathi sing dikarepake Celsion Corporation (IMNN)|PHIO - Bathi resik sing dikarepake|Mustang Bio Inc - Bathi mangsa ngarep|Proyeksi bathi mangsa ngarep transcodetherapeutics.com RNAZ|Bionano Genomics Inc. - Proyeksi bathi mangsa ngarep|APDN (Applied DNA Sciences) - Prakiraan bathi resik|BLUE (bluebirdbio.com) - Bathi mangsa ngarep|Prakiraan bathi resik IPA|OMGA (omegatherapeutics.com) - Proyeksi bathi mangsa ngarep|Singular Genomics Systems Inc (OMIC) - Prakiraan bathi perusahaan|Proyeksi bathi mangsa ngarep RGLS|Prakiraan bathi perusahaan Syros Pharmaceuticals, Inc.|Bathi sing dikarepake Telesis Bio Inc. TBIO|Bathi resik mangsa ngarep TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Proyeksi bathi mangsa ngarep